相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration
Baotong Zhang et al.
NATURE COMMUNICATIONS (2020)
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
Yixiang Li et al.
THERANOSTICS (2020)
IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis
Mengmeng Liang et al.
CELL DEATH & DISEASE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
HDAC-mediated deacetylation of KLF5 associates with its proteasomal degradation
Ran Tao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases A Randomized Clinical Trial
Andrew L. Himelstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience
Miriam Hegemann et al.
THERAPEUTIC ADVANCES IN UROLOGY (2017)
MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions
Jason Boyang Wu et al.
CANCER CELL (2017)
TGF-β Tumor Suppression through a Lethal EMT
Charles J. David et al.
CELL (2016)
被撤回的出版物: Transforming Growth Factor Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer (Retracted article. See vol. 295, pg. 4368, 2020)
Yang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
M. Katie Conley-LaComb et al.
MOLECULAR CANCER (2016)
Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation
Benjamin G. Barwick et al.
NATURE IMMUNOLOGY (2016)
Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
Rong Liu et al.
THERANOSTICS (2016)
A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
Takuya Sakamoto et al.
PLOS ONE (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
A pivotal role of Kruppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma
Osamu Maehara et al.
CANCER BIOLOGY & THERAPY (2015)
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Pierrick G. J. Fournier et al.
CANCER CELL (2015)
Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2015)
Survival with Newly Diagnosed Metastatic Prostate Cancer in the Docetaxel Era'': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Nicholas David James et al.
EUROPEAN UROLOGY (2015)
Targeting bone metastases in prostate cancer: improving clinical outcome
Jean-Jacques Body et al.
NATURE REVIEWS UROLOGY (2015)
Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells
Xin Li et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Roles of Klf5 Acetylation in the Self-Renewal and the Differentiation of Mouse Embryonic Stem Cells
Tong Zhao et al.
PLOS ONE (2015)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Managing bone metastases and reducing skeletal related events in prostate cancer
Benjamin A. Gartrell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1
Arun Bhardwaj et al.
ONCOTARGET (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression
Z. Dong et al.
CELL PROLIFERATION (2013)
Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers
Courtney Morisson et al.
CURRENT OPINION IN UROLOGY (2013)
Targeting TGF-β signaling in cancer
Lior H. Katz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Denosumab and Bone Metastasis-Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
Matthew R. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
KLF5 Activates MicroRNA 200 Transcription To Maintain Epithelial Characteristics and Prevent Induced Epithelial-Mesenchymal Transition in Epithelial Cells
Baotong Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells
Changsheng Xing et al.
PLOS ONE (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
Xinhai Wan et al.
BONE (2012)
Human Bone Marrow-Derived Mesenchymal Stem Cells Produced TGFbeta Contributes to Progression and Metastasis of Prostate Cancer
Huamao Ye et al.
CANCER INVESTIGATION (2012)
Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
Zebin Hu et al.
HUMAN GENE THERAPY (2012)
Complexities of TGF-β Targeted Cancer Therapy
Erin C. Connolly et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Urszula M. Domanska et al.
NEOPLASIA (2012)
TGF-beta in cancer and bone: Implications for treatment of bone metastases
Patricia Juarez et al.
BONE (2011)
HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs
Bin Zheng et al.
CELL RESEARCH (2011)
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
Saima Hassan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?
A. C. Hirbe et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases
Jin-Tang Dong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition
Carl-Henrik Heldin et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Mechanisms of the epithelial-mesenchymal transition by TGF-beta
Michael K. Wendt et al.
FUTURE ONCOLOGY (2009)
Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification
Peng Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-β-mediated Induction in Epithelial Cells
Peng Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Opposing Effects of KLF5 on the Transcription of MYC in Epithelial Proliferation in the Context of Transforming Growth Factor β
Peng Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone
Sreenivasa R. Chinni et al.
MOLECULAR CANCER RESEARCH (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Molecular biology of bone metastasis
Lauren A. Kingsley et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells
CS Chen et al.
ONCOGENE (2005)
Prostate cancer bone metastases promote both osteolytic and osteoblastic activity
ET Keller et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Pathophysiology of bone metastases in prostate cancer
PA Abrahamsson
EUROPEAN UROLOGY SUPPLEMENTS (2004)
Transforming growth factor-beta in osteolytic breast cancer bone metastases
TA Guise et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)
Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain
S Miyamoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Biology of osteoclast activation in cancer
GD Roodman
JOURNAL OF CLINICAL ONCOLOGY (2001)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
分享论文
